Fibroblast growth factor-23, a phosphaturia hormone that regulates phosphate and vitamin D homeostasis, has been implicated in osteosarcoma progression 16 and tumor-PTHrP-induced hypercalcemia as well as osteolytic lesions and metastatic spread 39. Here, FGF23 is linked to hypercalcemia disease.